These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14631491)

  • 1. Interrelation between compensation of carbohydrate metabolism and severity of manifestations of oxidative stress in type II diabetes mellitus.
    Nedosugova LV; Lankin VZ; Balabolkin MI; Konovalova GG; Lisina MO; Antonova KV; Tikhaze AK; Belenkov YN
    Bull Exp Biol Med; 2003 Aug; 136(2):132-4. PubMed ID: 14631491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in patients with chronic heart failure and type 2 diabetes mellitus.
    Arzamastseva NE; Lankin VZ; Konovalova GG; Tikhaze AK; Ageev FT; Lapina YV; Narusov OY; Mareev VY; Belenkov YN
    Bull Exp Biol Med; 2007 Feb; 143(2):207-9. PubMed ID: 17970203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of glucose on the free radical peroxidation of low density lipoproteins in vitro and in vivo].
    Lankin VZ; Konovalova GG; Tikhaze AK; Nedosugova LV
    Biomed Khim; 2012; 58(3):339-52. PubMed ID: 22856139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.
    Babiy AV; Gebicki JM; Sullivan DR; Willey K
    Biochem Pharmacol; 1992 Mar; 43(5):995-1000. PubMed ID: 1554398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications.
    Fenercioglu AK; Saler T; Genc E; Sabuncu H; Altuntas Y
    J Endocrinol Invest; 2010 Feb; 33(2):118-24. PubMed ID: 19834314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antioxidant properties of gliclazide.
    O'Brien RC; Luo M; Balazs N; Mercuri J
    J Diabetes Complications; 2000; 14(4):201-6. PubMed ID: 11004429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus.
    Aouacheri O; Saka S; Krim M; Messaadia A; Maidi I
    Can J Diabetes; 2015 Feb; 39(1):44-9. PubMed ID: 25065473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
    Oranje WA; Rondas-Colbers GJ; Swennen GN; Jansen H; Wolffenbuttel BH
    Diabetes Care; 1999 Dec; 22(12):2083-4. PubMed ID: 10587847
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.
    Julier K; Mackness MI; Dean JD; Durrington PN
    Diabet Med; 1999 May; 16(5):415-23. PubMed ID: 10342342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antioxidant enzymes and antioxidant compound probucol in antiradical protection of pancreatic beta-cells during alloxan-induced diabetes.
    Lankin VZ; Korchin VI; Konovalova GG; Lisina MO; Tikhaze AK; Akmaev IG
    Bull Exp Biol Med; 2004 Jan; 137(1):20-3. PubMed ID: 15085236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
    Harada N; Kashiwagi A; Nishio Y; Kikkawa R
    Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia.
    Ceriello A; Bortolotti N; Motz E; Pieri C; Marra M; Tonutti L; Lizzio S; Feletto F; Catone B; Taboga C
    Metabolism; 1999 Dec; 48(12):1503-8. PubMed ID: 10599980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxidative stress on immunological parameters in type 2 diabetes mellitus in the Azerbaijan Republic.
    Yavari A; Azizova GI
    Diabetes Metab Syndr; 2012; 6(4):195-8. PubMed ID: 23199537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensification of free radical oxidation of low-density lipoproteins in the plasma of patients with ischemic heart disease receiving beta-hydroxy-beta-methylglutaryl-coenzyme A reductase inhibitor cerivastatin and inhibition of low-density lipoprotein peroxidation with antioxidant probucol.
    Lankin VZ; Tikhaze AK; Konovalova GG; Tutunov VS; Medvedeva NV; Kotkina TI; Kukharchuk VV; Belenkov YN
    Bull Exp Biol Med; 2002 Jul; 134(1):39-42. PubMed ID: 12459865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous subcutaneous insulin infusion in patients with type 2 diabetes: a cohort study to establish the relationship between glucose control and plasma oxidized low density lipoprotein.
    Megson IL; Treweeke AT; Shaw A; MacRury SM; Setford S; Frias JP; Anhalt H
    J Diabetes Sci Technol; 2015 May; 9(3):573-80. PubMed ID: 25652563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic drugs induce antioxidant aldehyde dehydrogenase activity and remain high in patients with glycemic control in type 2 diabetes.
    Picazo A; Jiménez-Osorio AS; Zúñiga-Mejía P; Pedraza-Chaverri J; Monroy A; Rodríguez-Arellano ME; Barrera-Oviedo D
    Eur J Pharmacol; 2017 Apr; 800():57-62. PubMed ID: 28216053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
    Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
    Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes.
    Gorogawa Si; Kajimoto Y; Umayahara Y; Kaneto H; Watada H; Kuroda A; Kawamori D; Yasuda T; Matsuhisa M; Yamasaki Y; Hori M
    Diabetes Res Clin Pract; 2002 Jul; 57(1):1-10. PubMed ID: 12007724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.